Answers are grounded in this paper and cite their sources.
mouse models. EFEMP1 protein levels were increased in AMD tissue, and ASO-mediated EFEMP1 knockdown reduced complement factor 3 (C3), suppressed HMREC proliferation and migration, and inhibited angiogenic sprouting in choroidal explants. These findings support EFEMP1 as a pathogenic regulator of retinal degeneration and vascular dysfunction and establish EFEMP1-directed ASOs as a promising therapeutic strategy for ADD and AMD.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: